Controversial lesions in pancreas biopsy grading
description
Transcript of Controversial lesions in pancreas biopsy grading
![Page 1: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/1.jpg)
Pancreas Transplant Pathology: Controversial
Lesions
Lois J. Arend PhD, MD
University of Cincinnati Department of Pathology
![Page 2: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/2.jpg)
American Journal of Transplantation 2008; 8: 1237–1249Banff Schema for Grading Pancreas Allograft Rejection: Working Proposal by a Multi-Disciplinary International Consensus PanelC. B. Drachenberg, J. Odorico, A.J. Demetris, L. Arend, I. M. Bajema,J. A. Bruijn, D. Cantarovich, H. P. Cathro, J. Chapman, K. Dimosthenous,B. Fyfe-Kirschner, L. Gaber, O. Gaber, J. Goldberg, E. Honsova, S. S. Iskandar, D. K. Klassen, B. Nankivell, J. C. Papadimitriou, L. C. Racusen, P. Randhawa, F. P. Reinholt, K. Renaudin, P. P. Revelo, P. Ruiz, J. R. Torrealba, E. Vazquez-Martul, L. Voska, R. Stratta, S. T. Bartlett and D. E. R. Sutherland
![Page 3: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/3.jpg)
1. Normal2. Indeterminate 3. Cell-mediated rejection
Acute cell-mediated rejection- Grade I/Mild acute cell-mediated rejection- Grade II/Moderate acute cell-mediated rejection- Grade III/Severe acute cell-mediated rejection
Chronic active cell-mediated rejection4. Antibody-mediated rejection = C4d + donor specific antibodies + graft
dysfunctionHyperacute rejectionAccelerated antibody-mediated rejectionAcute antibody-mediated rejectionChronic active antibody-mediated rejection
5. Chronic allograft rejection/graft sclerosis- Stage I (mild graft sclerosis)- Stage II (moderate graft sclerosis)- Stage III (severe graft sclerosis)
6. Other histological diagnosis. e.g. CMV pancreatitis, PTLD, etc.
Allograft Pancreas Grading
American Journal of Transplantation 2008; 8: 1237–1249
![Page 4: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/4.jpg)
Outline
• Drug Toxicity• Significance of C4d Labeling• Significance of Acinar Inflammation• Chronic Rejection/Sclerosis
![Page 5: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/5.jpg)
Drug Toxicity
• Exocrine pancreas– Acute pancreatitis
• Anti-neoplastics, sulfonamides, diuretics, alcohol, azathioprine, oral contraceptives
• Acinar cell necrosis or apoptosis, inflammation, necrosis
• Endocrine pancreas– Diabetes
• Calcineurin inhibitors, thiazide diuretics• Vacuolation, swelling, apoptosis of islet cells• Reduced insulin staining of beta cells
![Page 6: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/6.jpg)
Exocrine Pancreas
• Acute pancreatitis– Drugs, duct obstruction, viruses, toxic
chemicals, trauma• Some features of acute pancreatitis can
overlap with acute rejection• Distinguishing between the two can be difficult• Venulitis and more mononuclear dominant
infiltrate favors rejection• Many centers will treat for rejection if no clinical
reason for pancreatitis is evident
![Page 7: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/7.jpg)
Endocrine Pancreas• Diabetes
– Caused by immunosuppressive agents• No inflammation – vacuolation or drop-out
– Caused by recurrent autoimmune disease• Mononuclear cell infiltrate, similar to rejection
– Should routine immunostaining be included as part of the grading scheme?
• Immunostaining for insulin and glucagon may not be routine at some centers
![Page 8: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/8.jpg)
Significance of C4d Staining
• Antibody-mediated rejection, complement activation, deposition on endothelial cells– Indication of AMR
• Acute
• Chronic?
• Accessibility of staining by IHC on paraffin• Non-specificity of paraffin section staining• Frozen sections for IF?
![Page 9: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/9.jpg)
Significance of C4d Staining• Correlation between C4d+ IAC and:
– Development of DSA
– Allograft dysfunction
• C4d staining of artery intima or media, and interstitial collagen– No correlation with DSA or dysfunction
• Islet capillaries– No correlation with DSA or blood glucose
• C4d+ IAC correlated with DSA and graft dysfunction
Torrealba, et al Transplantation 2008; 86: 1849
![Page 10: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/10.jpg)
Retrospective Review of C4d Staining
• 2003 – 2009
• 22 biopsies with C4d immunostaining performed
• 2 cases with C4d+ IAC labeling
• No correlation with rejection grade– Sclerosing grade III; ACR III (old grade V)
• DSA not available
![Page 11: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/11.jpg)
![Page 12: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/12.jpg)
![Page 13: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/13.jpg)
![Page 14: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/14.jpg)
![Page 15: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/15.jpg)
![Page 16: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/16.jpg)
![Page 17: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/17.jpg)
![Page 18: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/18.jpg)
![Page 19: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/19.jpg)
![Page 20: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/20.jpg)
Significance of Acinar Inflammation –
• Mild acinar inflammation and injury to acinar cells (Grade I)
• Acinar injury easily leads to fibrosis
• Fibrosis -> poor prognosis
![Page 21: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/21.jpg)
Significance of Acinar Inflammation –
• Mayo clinic study
• 2 year period – 18 biopsies for grade II
• 25 follow-up biopsies
• 10 were unchanged, 1 grade III, 1 grade IV
• Conclusion: Grade II may not have unfavorable prognosis
Casey, et al., Transpl, 2005
![Page 22: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/22.jpg)
Significance of Acinar Inflammation –
• Minnesota study
• 8 year period – 914 pancreas grafts
• 80 grafts lost to chronic rejection
• 91% of these had prior rejection episode
• 70% with late functioning grafts had never had acute rejection
Humar, et al., Transpl, 2003
![Page 23: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/23.jpg)
Cincinnati Experience –
• Small sample
• Two cases with Grade II rejection
• One graft progressed to Stage III sclerosis in one year
• One graft progressed to Stage III sclerosis in nine months
![Page 24: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/24.jpg)
1 month post-txp
![Page 25: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/25.jpg)
![Page 26: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/26.jpg)
4 months post-txp
![Page 27: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/27.jpg)
7 months post-txp
![Page 28: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/28.jpg)
10 months post-txp
![Page 29: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/29.jpg)
![Page 30: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/30.jpg)
12 months post-txp
![Page 31: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/31.jpg)
![Page 32: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/32.jpg)
Proposal –
• Should acinar inflammation of any degree be considered severe and treated aggressively?
– Septal category of rejection
– Acinar category– Arteritis category
![Page 33: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/33.jpg)
Treatment of rejection
• Treat any form of pancreatic rejection aggressively– All but mildest cases treated with anti-
thymocyte therapy
• Low threshold for treatment of pancreas rejection
![Page 34: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/34.jpg)
Chronic Rejection/Sclerosis
• Is graft sclerosis always due to rejection?
• Drug toxicity, infections, vascular complications
• Avoid CAN analog ?CAP
• Distinguish cause of sclerosis if possible
![Page 35: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/35.jpg)
![Page 36: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/36.jpg)
![Page 37: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/37.jpg)
Summary
• Distinguishing rejection from many other insults can be difficult
• Significance of C4d+ unclear
• Any degree of acinar inflammation may benefit from early aggressive treatment
• Defining causes of chronic injury
• Rejection grade correlation with outcome
![Page 38: Controversial lesions in pancreas biopsy grading](https://reader036.fdocuments.us/reader036/viewer/2022081414/54b5b5c94a79598e708b4692/html5/thumbnails/38.jpg)
Acknowledgements
SurgerySteve Woodle, MD
Transplant PharmacyJason Everly, PharmDRita Alloway, PharmD
NephrologyPrabir Roy-Chaudhury, MDGautham Mogilishetty, MDAmit Govil, MD
PathologyPravina Desai
NEJM 356; 2007